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Abstract
Background: Although evidence shows the positive health effects of physical activity, most of the adult population
in Colombia are sedentary. It is, therefore, important to implement strategies that generate changes in lifestyle
behaviours. This protocol describes a study in which we will compare the effects of 12 weeks of high-intensity
interval training (HIIT), resistance training (RT) or combined training (HIIT + RT) on the improvement of body
composition, endothelial function, blood pressure, blood lipids, and cardiorespiratory fitness in a cohort of
sedentary, overweight adults (aged 30–50 years).
Methods/design: Sixty sedentary, overweight adults attending primary care in Bogotá, Colombia will be included
in a factorial randomised controlled trial. Participants will be randomly assigned to the following intervention
groups: (1) non-exercise group: usual care with dietary support, (2) HIIT group: 4 × 4-min intervals at 85–95 %
maximum heart rate (HRmax) (with the target zone maintained for at least 2 minutes), interspersed with a 4-min
recovery period, at 65 % HRmax, (3) RT group: completing a resistance circuit (including upper and lower muscle
groups) as many times as needed according to subject’s weight until an expenditure of 500 kcal at 40–80 % of
one-rep max (1RM) has been achieved, and (4) combined group: HIIT + RT. The primary end point for effectiveness
is vascular function as measured by flow-mediated vasodilatation 1 week after the end of exercise training.
Discussion: The results of this study will provide new information about the possible effect of the programme in
improving the cardiometabolic health of overweight adults, making a more efficient use of an adult’s resources
over time.
Trial registration: ClinicalTrials.gov ID: NCT02715063. Registered on 8 March 2016.
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Background
The prevalence of obesity has increased worldwide [1]
among both children and adults, and obesity is associated
with an increased risk for cardiovascular diseases (CVD)
[2, 3]. Substantial evidence indicates that increased body
weight and body fat distribution are associated with a
higher frequency of adverse health consequences, includ-
ing hypertension, CVD, metabolic disorders, osteoarth-
ritis, gallbladder stone disease, asthma and multiple
malignancies [4, 5]. International organisations [6, 7] and
previous epidemiological cross-sectional studies have sug-
gested that individuals with a large accumulation of body
fat in the abdominal region are at greater risk for the de-
velopment of metabolic syndrome [8, 9]. In addition to
obesity, hypertension, dyslipidaemia and low cardiorespi-
ratory fitness (CRF) are also modifiable risk factors associ-
ated with the risk for CVD [10, 11]. Furthermore, it has
become increasingly clear that low CRF may exacerbate
the risk of CVD mortality, and that increasing peak CRF
to higher than 5 peak metabolic equivalents (MET) can
reduce and perhaps eliminate the mortality rate associated
with dyslipidaemia, obesity, type 2 diabetes mellitus and
hypertension [12].
The health benefits of exercise training are well docu-
mented; it is necessary for healthy growth and develop-
ment because it optimises cardiometabolic function and
prevents chronic disease [13, 14]. Additionally, its bene-
fits are not only biological, but also include psychosocial
advantages [15]. The most recent guidelines promoted
by the World Health Organisation (WHO) recommend
a minimum of 150 min of moderate-intensity physical
activity (3 to <6 MET) or 75 min of vigorous-intensity
physical activity (≥6 MET per week or any equivalent
combination for health benefits, and 300 min of
moderate-intensity physical activity or 150 min of
vigorous-intensity physical activity per week for add-
itional health benefits [16, 17].
Previous studies have reported improvement in endo-
thelial function in different disorders, such as obesity, dia-
betes mellitus and metabolic syndrome, by increasing the
production and bioactivity of nitric oxide [18–21]. In
addition, a growing body of evidence has demonstrated
comparable or superior improvements in cardiometabolic
health outcomes using low-volume, high-intensity interval
training (HIIT) compared to traditional moderate-
intensity continuous training (MICT) [18, 19]. Other stud-
ies have revealed a strong relationship between vascular
function and CRF [20, 21]. Thus, because HIIT is a potent
method of improving CRF, several systematic and narra-
tive reviews that have investigated the impact of HIIT
relative to MICT on vascular function in clinical patients
have emerged over recent years [18, 19, 22]. HIIT provides
rapid physiological adaptations, as indicated by improve-
ments in maximal oxygen uptake (VO2max), anaerobic
threshold and stroke volume [23, 24]. Instead, it was sug-
gested that the ability of HIIT to restore vascular homeo-
stasis through enhancement in shear stress-induced nitric
oxide bioavailability may be another important mechan-
ism that explains the protective role of exercise against
CVD development [25].
Interestingly, despite the prevalence of obesity and the
existing multiple position stands promoting exercise for
the treatment of obesity, there are few randomised trials
that have directly compared the effects of sustained re-
sistance training (RT), HIIT, or a combination of the two
(RT + HIIT) to be as effective or more effective for im-
proving cardiometabolic health in adults [26, 27]. Most
of the published studies addressing RT and fat mass
changes have compared RT to an inactive control group
and not to HIIT. Furthermore, existing studies have not
directly studied comparable amounts of HIIT and RT. A
recent randomised controlled trial (RCT) suggests that
adding plyometric exercises to a HIIT programme may
be more beneficial than HIIT alone in young obese
women [28]. Given the increasing burden of chronic
disease, more research is needed to better understand
the effect of different exercise modalities on these risk
factors [29].
Thus, this paper describes the rationale, design, and
methodologies used in a factorial randomised controlled
trial (Cardiometabolic HIIT-RT Study), wherein we
hypothesised that HIIT and combined training would re-
sult in greater improvements in vascular function com-
pared to RT and usual clinical care.
Methods/design
Study design and setting
The present study is a RCT (ClinicalTrials.gov ID:
NCT02715063). The Cardiometabolic HIIT-RT Study is
a single-blind, randomised controlled, 2 × 2 factorial
trial. The study received ethical approval from the Med-
ical Research Ethics Committee of The University of
Manuela Beltran (ID 06-1006-2014). Random allocation
to treatment will be performed at the individual level.
Procedures
Participants
Participants aged 30–50 years, who are sedentary (no
participation in exercise more than once a week for the
previous 6 months) with abdominal obesity: waist cir-
cumference (WC) at least 90 cm for men, and at least
80 cm for women, or with excess weight: body mass
index (BMI) at least 25 kg/m2 for men and 35 kg/m2 for
women, and who are identified as being willing and with
almost immediate availability, will be enrolled. Eligible
subjects for the present study and those interested in
participating will be invited to a pre-test that includes an
interview in a private health care institution (Clinica
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Rangel Pereira IPS) and further assessments performed
at the Centre of Studies in Physical Activity Measure-
ments (in Spanish, CEMA), School of Medicine and
Health Sciences, University of Rosario, Bogotá,
Colombia. Risks will be minimised by ruling out contra-
indications to the testing and training protocols via a
health history and thorough physical examination prior
to the testing sessions. Inclusion and exclusion criteria
are provided in Table 1.
Recruitment
Consecutive men or women with abdominal obesity
or excess weight will be recruited from a private
health care institution (Clinica Rangel Pereira, IPS)
and one primary care institution (Universidad del
Rosario, IPS) that receives referrals from both medical
consultants in secondary care and primary care gen-
eral practitioners in the capital district of Bogotá,
Cundinamarca Department in the Andean region.
This region is located at approximately 4°35′56″N 74°
04′51″W and at an elevation of approximately
2625 m (min: 2500 m; max: 3250 m) above sea level
[30]. Subjects who are interested in participating will
be approached with further information and screened
for pre-participation exercise habits using a cardiovas-
cular and musculoskeletal checklist (i.e. the patient’s
medical history, disease history, physical fitness, and
more). A member of the research team will follow up
with a phone call to screen for eligibility and explain
the main requirements of the study. All participants
will provide written informed consent before entering
the study.
Blinding and randomisation methods
The randomisation into the four study arms will be
performed by the Centre of Studies in Physical Activ-
ity Measurements at University of Rosario, Bogotá,
Colombia, using block randomisation with a block size
of four. Eligible participants will be randomly assigned
after completing the baseline measurements to either
the control or exercise training groups. The principal
investigator will coordinate the allocation sequence,
and randomisation will be computer-generated. All
participants and study personnel (including investiga-
tors, trainers, and statisticians) will be blinded to
treatment allocation throughout the trial protocol. Ac-
cess to the allocation code will be restricted to one
study statistician who will not perform the final study
analyses. Randomisation will be conducted independ-
ently using sealed opaque envelopes. These procedures
are also detailed in the study operations manual.
Moreover, the importance of maintaining the blinding
and allocation concealment will be reinforced by regu-
larly scheduled conference calls at the sites and daily
meetings with the field investigators (Fig. 1).
Table 1 Inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
Central obesity: waist circumference ≥90 cm (men); ≥80 cm (women), or
with excess weight: body mass index ≥25 kg/m2 (men) and≤ 35 kg/m2
(women)
Systemic infections
Meets at least one criteria for metabolic syndrome (IDF 2006):
triglycerides ≥150 mg/dl; HDLc <40 mg/dL (men); <50 mg/dL (women);
high blood pressure ≥130/85 mmHg and/or fasting plasma glucose
≥100 mg/dL
Weight loss or gain of >10 % of body weight in the past 6 months
for any reason
Written informed consent Currently taking medication that suppresses or stimulates appetite
Interested in improving cardiovascular health and physical fitness Uncontrolled hypertension: systolic blood pressure 160 mmHg or diastolic
blood pressure 95 mmHg on treatment
Gastrointestinal disease, including self-reported chronic hepatitis or cirrhosis,
any episode of alcoholic hepatitis or alcoholic pancreatitis within the past
year, inflammatory bowel disease requiring treatment within the past year,
recent or abdominal surgery (e.g. gastrostomy)
Asthma
Diagnosed diabetes (type 1 or 2), fasting impaired glucose tolerance
(blood glucose 118 mg/dL), or use of any antidiabetic medications
Currently taking antidepressant, steroid, or thyroid medication, unless
dosage unstable (no change for 6 months)
Current exerciser (>30 min organised exercise per week).
Indication of unsuitability of current health for exercise protocol
(Physical Activity Readiness Questionnaire, PARQ)
Any other conditions which, in the opinion of the investigators, would
adversely affect the conduct of the trial
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Intervention
The participants who are randomly assigned to the inter-
vention group will participate in the cardiometabolic
programme.
1. Usual clinical care group
This group will receive usual clinical care according to
the consensus recommendations of the national goals for
cardiovascular health promotion and disease reduction of
the American Heart Association [31] and Colombian
guidelines COLDEPORTES (in Spanish, Departamento
Administrativo del Deporte, la Recreacion, la Actividad
Fisica y el Aprovechamiento del Tiempo Libre) [32]. Par-
ticipants will receive counselling about goals for cardio-
vascular health, as well as monitoring cardiovascular
health over time in the Colombian population, key signs
and symptoms, diet and screening for cardiometabolic risk
factors. This group will be asked to maintain their level of
activity during the 12-week study period.
2. High-intensity interval training (HIIT) group
The HIIT protocol will be completed with fast walking
or running on a treadmill with the deck inclined to reach
the desired intensity. We will calculate the training energy
expenditure for participants’ age ranges associated with
meeting the consensus public health recommendations
from the WHO [16] and the US Department of Health
and Human Services [17]. Each preparatory period starts
with an exercise dose of 6 kcal kg-1 week-1, which will
increase progressively by 2 kcal kg-1 week-1 until week 4,
where it will remain at 12 kcal kg-1 week-1 for weeks 5 to
12.
Preparatory training phase: weeks 1–4
To initiate our study we will use a 4-week preparatory
phase of training to bring all participants up their 300-
kcal goal for the session. To accomplish this they will
warm up at 65 % of maximum heart rate (HRmax)
(5 min); exercise for 4 × 4-min intervals at 60–80 %
HRmax, interspersed with a 4-min recovery period at
55 % HRmax, at a frequency of three times per week.
Protocol of interval training: weeks 5–12
The overall goal for the HIIT group is to perform exer-
cise sessions in 4 × 4-min intervals at 85–95 % HRmax
(with the target zone maintained for at least 2 minutes),
interspersed with a 4-min recovery period at 65 %
HRmax. During each exercise session, participants will
adhere to the 12-kcal kg-1 week-1 energy expenditure
format, equivalent to 500 kcal of expended energy at the
end of training and cool-down (5 min), with a range
total exercise time of 35 to 45 min (Fig. 2). Exercise will
be performed for three sessions per week. During the su-
pervised intervention, we will record HR using an HR
monitor (Polar Pacer, Lake Success, NY, USA) to ensure
compliance with the exercise stimulus at the predeter-
mined target HR zone. In addition, HR and Borg ratings
will also be measured in each exercise session.
3. Resistance training group
Preparatory training phase: weeks 1–4
Fig. 1 Consolidated Standards of Reporting Trial (CONSORT) guidelines flow diagram for enrolment and randomisation in the Cardiometabolic
HIIT-RT Study
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All participants will complete a base resistance train-
ing protocol during the 2 weeks prior to the training
intervention (Table 2). This phase will encompass a total
of three workouts (Monday, Wednesday, and Friday)
during the 4 weeks. During the adaptation phase, the
subjects will expend energy up to 300 kcal at 20–50 % of
one repetition maximum (1RM), for 2 × 20–30 repeti-
tions with 1-min rest intervals. During each exercise ses-
sion, participants will adhere to the 6–8 kcal kg-1 week-1
energy expenditure format. The purpose of the prepara-
tory phase will be to instruct proper lifting technique, fa-
miliarise participants with all exercises, and ensure that
the participants began the study with a comparable
training base.
RT protocol: weeks 5–12
After the preparatory phase, participants will expend
500 kcal of energy during the protocol training phase at
40–80 % of 1RM, for 4 × 20–30 repetitions and 1-min
rest intervals. The RT protocol will be used to complete
a resistance circuit (including upper and lower muscle
groups; eight exercises); all participants will expend en-
ergy up to the 500-kcal goal. The entire workout will last
approximately 30–40 minutes, depending on the num-
ber of exercises (Table 2), at a frequency of three times
per week. Each session is preceded and followed by a
gradual warm-up and cool-down period (both of 10-min
duration and consisting of walking and light, static
stretching (avoiding muscle pain) in most muscle
groups). The cool-down period also includes relaxation
and stretching exercises. The RT protocol will be per-
formed through the full range of motion normally asso-
ciated with correct technique for each exercise, engaging
the major muscle groups (abdominal, dorsal, shoulder,
upper and lower limb muscles). As a general rule and to
avoid potential risks, we will avoid (1) activities that in-
clude Valsalva’s mechanism, (2) ballistic and plyometric
movements, and (3) positions of extreme muscular ten-
sion. This resistance training programme has been used
before, successfully promoting strength and muscle gains
in middle-aged and elderly populations with a variety of
conditions (e.g. diabetes type II and obesity) [33, 34].
4. Combined training group
This group will receive both the HIIT and RT proto-
cols as described above. Therefore, the energy expend-
iture associated with the physical training prescribed for
the vigorous-intensity group will be approximately
1500 kcal/week.
Overall, we will monitor each subject’s HR (FS1, Polar
Electro Öy, Kempele, Finland) during the exercise ses-
sions. We will estimate the energy expenditure during
the exercise sessions by calibrating the energy expend-
iture to the HR during the VO2max tests performed at
the baseline and post-intervention time points. The re-
gression of the energy expenditure will be calculated for
each participant according to HR and minutes spent ex-
ercising during the training sessions. Trainers will be
physical therapists and physical educators with experi-
ence developing and monitoring exercise programmes
among clinical populations. All protocol training will be
performed under observation and supervision in an ex-
ercise laboratory with complete and strict monitoring of
the amount of exercise completed in each session. Ad-
herence to the exercise programme will be encouraged
by the exercise professional who supervises each of the
group sessions. To maximise adherence to the training
programme each session will have a maximum of three
to five participants training simultaneously. Attendance
at supervised sessions includes compliance with target
HR and expenditure energy and will be monitored and
recorded by research staff. Each participant will meet
with the study dietician for nutrition assessment and
counselling, and an individualised nutrition intervention
plan will be developed from the baseline food intake as-
sessment according to participant preferences [35]. This
plan is a standardised meal consisting of 1300 to
1500 kcal (50–55 % carbohydrates, 30–35 % total fat,
less than 7 % saturated fat and 15–22 % protein).
At the beginning of the training protocol, we will ob-
tain the participants’ weight to determine weekly energy
expenditure necessary to achieve their target of
12 kcal kg-1 week-1 (iso-energetic). It is expected that the
Fig. 2 Example of a 30–40-min 4 × 4 high-intensity interval training (HIIT) session
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gradual increase in total energy expenditure will minim-
ise fatigue, soreness, injuries, and attrition.
Data collection and outcome measures
Outcome measures will be assessed at baseline and at
12-week follow-up by personnel blinded to the treat-
ment allocation. Data will be recorded on standardised
forms and entered into a secured-access database that
contains quality control checks (e.g. range checks, notifi-
cation of missing data).
The primary outcome measure is endothelial function as
measured by flow-mediated dilatation (FMD). The secondary
outcome variables include HR variability, pulse wave velocity
(PWV), weight, BMI, WC, body composition, body
temperature, biochemical profile, health-related physical
fitness, self-perceived health, health-related quality of life
(HRQL), and side effects. Other variables of interest include
24-hour dietary recall, lifestyle and demographic characteris-
tics (Table 3 and Figure 3).
Primary outcome measures
Endothelial function FMD will be measured with the
technique introduced by Ramírez-Vélez et al. [36] in the
STUDY PERIOD
Enrolment Allocation Post-allocation
TIMEPOINT** -t1 0
1-baseline
(week 0)
2-moment 
(week 4)
3-moment
(week 12)
ENROLMENT:
Eligibility screen X
Informed consent X
Allocation X
INTERVENTIONS:
Non-exercise 
group
HIIT group
RT group
Combined group
ASSESSMENTS:
Endothelial 
function 
X X
Vascular function
X X
Morphological 
component
X X X
Body Composition
X X
Body temperature
X X
Biochemical 
analysis
X X
Fitness component
X X
Self-perceived 
health
X X
Recent Physical 
Activity 
Questionnaire 
X X X
Demographic 
information
X X
Side effects
X X X
*According to SPIRIT 2013 statement.
Fig. 3 Schedule of enrollment, intervention and assessment*
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Colombian population using the guidelines reported by
Corretti et al. [37]. The diameter of the brachial artery
will be assessed using a high-resolution ultrasound de-
vice (Acuson Sequoia C512, Acuson Siemens, Mountain
View, CA, USA), equipped with a 7.5–10-MHz linear
array transducer and an integrated electrocardiography
package. The ultrasound procedures will be performed
with the subject resting quietly in a supine position for
at least 10 min. Measurements will be performed in the
morning (06.00–08.00 hours) due to diurnal variation in
a climate-controlled room (18–20 °C) with the lights
dimmed. All measurements will be taken at the end of
diastole as observed by electrocardiogram. First, the
diameter of the right brachial artery will be searched in a
cross-sectional view and then scanned over a longitu-
dinal section 5 to 10 cm proximal to the right elbow.
The diameter of the brachial artery will be measured
from the anterior to the posterior intima-lumen inter-
face at a fixed distance, calculating the mean diameter
from four cardiac cycles. After this, a pneumatic tourni-
quet placed around the right forearm will be rapidly in-
flated to at least 50 mmHg above the systolic blood
pressure for 5 min. A sudden release of the cuff will in-
duce an increase in blood flow in the brachial artery lo-
cated proximal to the tourniquet. During reactive
hyperaemia, shear stress will increase, causing
endothelium-dependent vasodilatation, mainly due to
endothelial release of nitric oxide [38, 39]. This second-
ary dilatation enhances and prolongs the reactive hyper-
aemic phase. FMD of the brachial artery will be
measured 45–60 s after cuff release. The change in
diameter caused by the increased flow will be calculated
as the percentage change relative to the baseline meas-
urement (FMD%). The intra-session coefficients of vari-
ation will be up to 1 % for baseline diameter. Reliability,
estimated by intra-class correlation coefficients (ICC)
based on four baseline measurements (n = 8 subjects),
showed an ICC of 0.91 for the baseline diameter and
0.83 for FMD (own date). Images will be recorded on a
DVD player for subsequent measurements by one obser-
ver blinded to the study.
Secondary outcomes
Heart rate variability Measurement of HR variability
will be performed according to current recommenda-
tions by the European Society of Cardiology using an
evaluated share-ware (Kubios, vers. 2.0; http://kubio-
s.uef.fi/) [40]. The variations in interbeat intervals in the
time domain will be quantified by the mean values and
standard deviations of normal interbeat intervals in the
supine position.
Aortic pulse wave velocity (PWV) and augmentation
index (AIx) Both PWV and AIx will be measured with
the oscillometric method using the occlusion technique.
Patient data and the measured distance between the
jugulum and the symphysis will be registered in the
arteriography-programmed computer (TensioMed Soft-
ware v.1.9.9.2; TensioMed, Budapest, Hungary). A tape
measure will be used for measuring the distance
Table 2 Resistance training programme
Programme variable Preparatory
phase
Volume Intensity
Preparatory training
phase
Exercise prescription 20–40 % 1RM 40 % 1RM 30–50 % 1RM
Training intensity 2 × 20–30
repetitions
2 × 20–30
repetitions
2 × 20–30
repetitions
Training volume 1 min 30 s 1 min
Energy expenditure 300 kcal
Rest time Weeks 1 to 4
Specific exercises
Barbell squats
Split squats
Biceps curls
Dumbbell lateral
raises shoulder
Dumbbell military
shoulder press
Dumbbell triceps
curls
Resistance training
protocol
Exercise prescription 40–60 % 1RM 70 % 1RM 70–80 % 1RM
Training intensity 4 × 20–30
repetitions
4 × 20–30
repetitions
4 × 20–30
repetitions
Training volume 1 min 30 s 1 min
Energy expenditure 500 kcal
Rest time Weeks 1 to 4
Specific exercises
Barbell squats
Dumbbell squats
adductor
Split squats
Lateral adductor
squat
Biceps curls
Dumbbell lateral
raises shoulder
Dumbbell military
shoulder press
Dumbbell triceps
curls
Volume = sets × repetitions. 1RM one repetition maximum
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between the jugulum and the symphysis, namely the aor-
tic distance. The cuff will be placed on the patient’s
upper arm and connected to the device. Pressure varia-
tions in the cuff will influence a pressure receptor and
the signal, and will then be transferred via an infrared
port to the computer. The algorithm measuring blood
pressure in the arteriography device has been validated
[41]. PWV will be calculated as the jugulum and the
symphysis distance (m) divided by return time (return
time/2) (s). For PWV, two recordings with the lowest
standard deviation will be chosen. The standard devi-
ation will be calculated from every heartbeat during a
period of 8 s. Both aortic AIx (AIxao) and brachial AIx
(AIxbr) will be calculated as:
100 early systolic pressure peak−late systolic peakð Þ
=pulse pressureÞ:
The return time is the difference (in ms) between the
first (early systolic pressure peak) and reflected systolic
wave (late systolic peak) and is related to the stiffness of
the aorta. The PWV and AIx will be presented as the
mean values from two recordings. The algorithm for es-
timation of central systolic blood pressure (cSBP) has
been derived from the relationship between invasively
measured cSBP and the SBP in the brachial artery, and
cSBP estimated by arteriography correlates well with in-
vasively measured cSBP [41]. Blood pressure will be
measured at the same time of the day using a validated
digital automatic blood pressure monitor (OMRON M6,
Omron Health Care Co., Ltd., Kyoto, Japan) according
to the International Protocol of the European Society of
Hypertension [42].
Morphological component Anthropometric variables
will be assessed by a nutritionist in accordance to the
International Society for the Advancement of Kinanthro-
pometry (ISAK) guidelines [43]. Variables will be col-
lected at the same time in the morning, between 00.70
and 00.80 hours, following an overnight fast of at least
10–12 hours. The body weight of the subjects will be
measured when the subjects are in underwear and with-
out shoes, using electronic scales (Tanita® BC544, Tokyo,
Japan). The height of the subjects will be measured using
a mechanical stadiometer platform (Seca® 274, Hamburg,
Germany). The BMI of the subjects will be calculated as
the body weight in kilograms divided by the square of
the height in metres. The WC will be measured as the
narrowest point between the lower costal border and the
iliac crest; in case this is not evident, it will be measured
at the midpoint between the last rib and the iliac crest
using a tape measure (Ohaus® 8004-MA, Parsippany, NJ,
USA). The waist-to-height ratio will be computed by
dividing WC by height, and this provides a surrogate
measure of central body fat. We will take each measure
twice and use the average measure obtained, unless the
first and second measures vary by more than 1 %, in
which case we will use the median of three
measurements.
Body composition We will also measure fat mass, lean
body mass, abdominal adipose tissue and bone mineral
density by conducting a dual-energy X-ray absorptiometry
Table 3 Summary of time point measurements of the primary and secondary outcomes of the study
Type of
outcomes
Specific outcomes Measurements
1-baseline
(week 0)
2-moment
(week 4)
3-moment
(week 12)
Primary
outcomes
Endothelial function as measured by flow-mediated vasodilatation X X
Secondary
outcomes
Vascular function: heart rate variability, aortic pulse wave velocity, augmentation
index and blood pressure
X X
Morphological component: weight, height, BMI, waist circumference X X
Body composition: fat mass and non-bone lean body mass X X
Body temperature X X
Plasma samples and biochemical analysis: LDL cholesterol (LDL-c), HDL cholesterol
(HDL-c), total cholesterol, triglycerides, glucose, glycated haemoglobin (HbA1c)
X X
Fitness component: self-reported fitness, 1RM, hand-grip and peak uptake of vol-
ume of oxygen
X X
Self-perceived health: health-related quality of life X X
Recent Physical Activity Questionnaire X X X
Demographic information X
Side effects X X X
1RM one repetition maximum, BMI body mass index
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scan (DEXA) (Hologic, QDR 4500 W). An experienced
DEXA technologist who is blinded to the study random-
isation will perform the DEXA imaging studies.
Body temperature We will use a thermo-infrared cam-
era (FLIR Thermacam E60, FLIR systems, Boston, MA,
USA). Images in the frontal plane will be taken from the
anterior and posterior sides, according to the thermal
image acquisition criteria described by Ring and Ammer
[44]. During the measurement process, participants will
remain in their underwear and will maintain a steady
orthostatic position during the image acquisitions. The
distance from the camera to the subjects will be 2.5 m.
The study will be conducted according to the guidelines
of the American Academy of Thermography [45]. A sin-
gle investigator, trained in the use of thermographic de-
vices, will obtain the images.
Plasma samples and biochemical analysis A fasting
blood sample will be obtained from the cubital vein in
the early morning at the clinical care session attended by
the participants in the subset. The biochemical profile
will include: (1) plasma lipid triglycerides, total choles-
terol, high-density lipoprotein cholesterol (HDL-c), low-
density lipoprotein cholesterol (LDL-c) (by enzymatic
colourimetric methods); and (2) the metabolic regulators
glucose and haemoglobin A1C (HbA1c) (by enzymatic
colourimetric methods). All determinations will be ana-
lysed in serum using a Cardiocheck® and A1CNow+®
system.
Self-reported fitness Self-reported fitness will be deter-
mined by the International Fitness Scale (IFIS), which is
a questionnaire validated in European [46] and Colombian
adults [47]. IFIS consists of a Likert-type scale (range 1–5)
with five response options (very poor, poor, average, good,
and very good) about perceived overall fitness; its main
components include CRF, muscular strength, speed and
agility, and flexibility (http://www.helenastudy.com/IFIS).
IFIS has shown ‘high’ validity and ‘moderate’ to ‘good’ reli-
ability in young adults [48]. In Colombian adults, the in-
ternal consistency and reproducibility of IFIS items was
high (Cronbach’s alpha = 0.80) and the averaged ICC range
was 0.90–0.96 [47].
Health-related physical fitness Physical fitness will be
measured using tests that have previously shown high
validity and reliability levels. It will be determined using
a maximum treadmill exercise test (Precor TRM 885,
Treveso, Italy) following the modified Balke protocol
[49], which has been extensively used [50, 51] and vali-
dated [52]. The treadmill test will use a ramp protocol
where the inclination is constant (5.5 %) and the speed
increased by 0.5 km/h every minute, starting at 4 km/h.
Each session will begin with a 5- to 10-min warm-up at
50 W. We will ask participants to refrain from smoking
for 2 hours before the test, and from drinking alcohol or
doing any vigorous- or moderate-intensity activities for
48 h before the test. HRmax will be used to determine
the training intensity for each participant. We will meas-
ure blood pressure prior to and during the test. Exercise
will be terminated if participants are fatigued, or earlier
if they fulfill the ACSM’s guidelines for ‘Indications for
Terminating Exercise Testing’ [53]. CRF is defined as
the highest recorded VO2 value (VO2max) after two of
three criteria are met: (1) a plateau in VO2 after increase
in workload, (2) a respiratory exchange ratio >1.10, and
(3) a maximal HR within 10 bpm of their age-predicted
maximum. Muscular fitness will be assessed using the
hand-grip test (maximum hand-grip strength assess-
ment) using a standard adjustable handle analogue
hand-grip dynamometer T-18 TKK SMEDLY III® (Takei
Scientific Instruments Co., Ltd, Niigata, Japan). Partici-
pants will be given a brief demonstration and verbal in-
structions for the test and, if necessary, the
dynamometer will be adjusted according to the subject’s
hand size according to predetermined protocols. Hand-
grip strength will be assessed with the subject in a stand-
ing position with their shoulders adducted and neutrally
rotated, and their arms parallel but not in contact with
their body. The participants will be asked to squeeze the
handle for a maximum of 3–5 s, but no verbal encour-
agement will be given during the test. Two trials will be
allowed in each limb, and the average score will be re-
corded as peak hand-grip strength (kg). Thus, the values
of hand-grip strength presented will combine the results
of left- and right-handed subjects, without consideration
of hand dominance. Hand-grip will be adjusted by allo-
metric parameters defined by Jaric [54] (dynamometry/
weight0.67). Strength in the eight exercises will be
assessed at baseline and immediately after the interven-
tion ends. A general warm-up consisting of riding a
cycle ergometer for 5 min at a self-selected resistance
will precede strength testing. Standardised procedures
will be used to predict a one-rep max (1RM) from reps-
to-fatigue barbell squats, dumbbell adductor squats, split
squats, lateral adductor squat, biceps curls, dumbbell lat-
eral shoulder raises, dumbbell military shoulder press,
and dumbbell triceps curls from each participant’s per-
formance during the preparatory training phase [55].
Progressive overload will be achieved by increasing the
load when all prescribed repetitions (for a particular ex-
ercise) are achieved on two consecutive workouts [56].
Recent Physical Activity Questionnaire (RPAQ) Self-
reported physical activity is measured using the RPAQ.
This assesses physical activity across four domains (do-
mestic, recreational, work, commuting) over the
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previous month. It has shown moderate-to-high reliabil-
ity for physical activity energy expenditure and good val-
idity for ranking individuals according to their time
spent in vigorous intensity physical activity and overall
physical activity energy expenditure [57].
Health-related quality of life (HRQL) HRQL will be
measured by the SF Community - short-form survey
(SF-12™) Colombian version for physical and mental do-
mains’ summary scores and eight subscales (including vi-
tality) [58]. The internal consistency of the HRQL items
is moderate (Cronbach’s alpha = 0.70).
Sociodemographic information Baseline sociodemo-
graphic values, which could act as covariates or con-
founds for the tested treatment modality, will also be
collected. The surveys will include questions on age,
education, occupation, income, health history, and alco-
hol consumption, among others.
Dietary assessment To determine the average habitual
energy and macronutrient intake, a detailed 24-h diet
record will be obtained from all subjects 1 weekday and
1 weekend day during the 1-week baseline period. The
Food Intake Analysis Software (FAO/INFOODS, Report
of the Technical Workshop on Standards for Food Com-
position Data Interchange, Rome 2004) and national
food composition tables (for specific foods) will be used
to analyse total energy and macronutrient intake of each
subject’s 24-h diet.
Side effects and monitoring The study will be con-
ducted according to good clinical practice and standard
operating procedures. It will be monitored by the Hu-
man Rights Committee at the Universidad Manuela Bel-
trán Coordinating Centre composed of experts in
physical exercise, sports medicine, physical therapists,
physical educators and clinical epidemiologists. Interim
monitoring reports will be submitted to the experts, fo-
cusing on patient intake, adherence to the protocol,
baseline comparability of treatment groups, complete-
ness of data retrieval, and adverse events. All adverse
events will also be reported to the Universidad Manuela
Beltrán Ethics Committee. To standardise the study pro-
cedures, an operations manual has been written, and
comprehensive training sessions will be held prior to the
initiation of the trial. An independent researcher will be
in charge of auditing all assessment staff to record all of
these events for the participants over the study period.
Power calculation and sample size
The aim of this study is to obtain data on the effects
of HIIT, RT or combined training that will result in
similar improvements in cardiometabolic health
compared to the usual clinical care group. The meas-
urement of FMD, validated in several population
studies, was selected as the critical variable to calcu-
late the sample size [59, 60]. To calculate the re-
quired sample size, we will use the formula for the
comparison of two means:n ¼ Aþ B½ 2  2 SD2=DIF
F2; where n = the sample size required in each group,
SD = standard deviation of the outcome variable, and
DIFF = size of desired difference between groups. A
and B depend on the desired significance level and
desired power, respectively. Using estimates obtained
from the literature [59, 60] and our previously per-
formed study [61, 62], a sample size of 12 subjects in
each group will be needed to reach a power of 80 %
to detect a difference in means in the FMD of 2 % in
the FMD after 12 weeks of training, assuming a SD
of 2.7 using a two-sample t test with a 0.05 two-sided
significance level. Assuming a drop-out rate of 15 %,
the total minimal sample size has been increased to
15 subjects for each group. We believe that this sam-
ple size is feasible and realistic based on our previous
experiences in RCTs [33, 34, 59, 60, 63, 64].
Statistical analyses
The final data will be analysed using IBM SPSS 22.0
(SPSS, Inc., Chicago, IL, USA) and SAS software (SAS
Institute Inc., Cary, NC, USA). An exploratory analysis
will be performed to determine the frequency, range,
variability, and distribution type for each variable to use
the most appropriate statistical test when comparisons
will be necessary. These analyses permit the assessment
of the primary analysis of the data and will be under-
taken using the principle of intention-to-treat (ITT).
The ITT analysis for this study will include all partici-
pants, including those who are not fully compliant and
those with missing outcome data. Because this is an ex-
perimental design with two measures of the primary and
secondary outcomes, the first at baseline x0 (t0 = weeks)
and the second after interventions x1 (t1 = 12 weeks) in
four study groups, a comparative analysis between these
measures to establish differences will be executed. To
perform these comparisons, one-way ANOVA or
Kruskal-Wallis tests will be applied when appropriate.
Subsequently, a multivariate analysis will be carried out,
and the autocorrelation between repeated measures will
be taken into account. We will use longitudinal analysis
methods, such as a generalised estimating equation ap-
proach, to control the differences among measures at
baseline and to incorporate incomplete observations into
this analysis. Finally, we will investigate if there is an
interaction between the two interventions for the pri-
mary outcome at 12 weeks of supervised training HIIT,
RT or combined training (HIIT + RT). For these
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analyses, we will include appropriate interaction terms
in the models [38, 65]. The trial is not powered to detect
these interactions and is likely to have poor precision for
the interaction terms. We plan to report regression coef-
ficients for the interaction terms and their 95 % confi-
dence intervals. However, we aim to recruit 15
participants per group (a total of 60) to accommodate
for a 20 % attrition rate and elimination due to non-
compliance.
Dissemination
We will disseminate the results of our study via presen-
tations at international conferences and publications in
peer-reviewed journals. The study will be implemented
and reported in line with Standard Protocol Items for
Randomised Trials [66] Additional file 1.
Discussion
This protocol describes a study in which we will com-
pare the effects of 12 weeks of HIIT, RT or combined
training on improvements in body composition, endo-
thelial function, blood pressure, blood lipids, and cardio-
vascular fitness in a cohort of sedentary, overweight
adults (aged 30–50 years).
Latin American countries are experiencing different
stages of nutrition transition. Although the prevalence of
undernutrition is declining at different rates, the preva-
lence of overweight is dramatically increasing [67]. In
addition, physical inactivity and sedentary lifestyles are
also a preventable behaviour associated with obesity, but
the evidence on this issue remains mixed [68], and the
results might not be generalisable to all world regions
[69]. Thus, determining whether HIIT + RT can be a vi-
able public health approach to improve cardiometabolic
health is warranted, particularly given a recent finding
that HIIT added to plyometric exercise is more consist-
ently associated with improvements in metabolic abnor-
malities than HIIT alone.
We believe that our trial could help to determine
which type of programme better improves the cardio-
metabolic health of overweight adults and makes more
efficient use of an adult’s resources over time. In sum-
mary, the primary objective of the trial is to contribute
to the growing body of literature about physical exercise
interventions and cardiometabolic health among seden-
tary, overweight adults living in Bogotá, which will be
useful for designing innovative and time-efficient pre-
ventive measures among the Colombian population.
Trial status
The Cardiometabolic HIIT-RT Study began recruiting pa-
tients in March 2016 and will close recruitment in October
2016. Data collection will be completed in June 2017.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 122 kb)
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